Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.515, 2006-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Eptifibatide `highly cost-effective' for coronary stenting
Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. :
Access to resources
Recommend
Eptifibatide `highly cost-effective' for coronary stenting
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 340, 2001-01 ,pp. :
Coronary stenting "highly cost-effective" vs alteplase in MI
Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. :
Coronary stenting "highly cost-effective" in MI vs alteplase
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. :
Cilostazol "likely a cost-saving strategy" following stenting
Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. :